Details for New Drug Application (NDA): 201688
✉ Email this page to a colleague
The generic ingredient in TOBI PODHALER is tobramycin. There are eighteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the tobramycin profile page.
Summary for 201688
Tradename: | TOBI PODHALER |
Applicant: | Mylan Speciality Lp |
Ingredient: | tobramycin |
Patents: | 7 |
Suppliers and Packaging for NDA: 201688
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TOBI PODHALER | tobramycin | POWDER;INHALATION | 201688 | NDA | Mylan Specialty L.P. | 49502-401 | 49502-401-09 | 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-09) |
TOBI PODHALER | tobramycin | POWDER;INHALATION | 201688 | NDA | Mylan Specialty L.P. | 49502-401 | 49502-401-24 | 224 PACKAGE in 1 BOX, UNIT-DOSE (49502-401-24) / 56 BLISTER PACK in 1 PACKAGE / 4 CAPSULE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INHALATION | Strength | 28MG | ||||
Approval Date: | Mar 22, 2013 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Nov 4, 2030 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Nov 7, 2024 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jan 11, 2024 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 201688
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan Speciality Lp | TOBI PODHALER | tobramycin | POWDER;INHALATION | 201688-001 | Mar 22, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Mylan Speciality Lp | TOBI PODHALER | tobramycin | POWDER;INHALATION | 201688-001 | Mar 22, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Mylan Speciality Lp | TOBI PODHALER | tobramycin | POWDER;INHALATION | 201688-001 | Mar 22, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Mylan Speciality Lp | TOBI PODHALER | tobramycin | POWDER;INHALATION | 201688-001 | Mar 22, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Mylan Speciality Lp | TOBI PODHALER | tobramycin | POWDER;INHALATION | 201688-001 | Mar 22, 2013 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription